Diana Calogrias
Molecular Biology · 2009–2010
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 36 citations into it; #17,354 of 17,773 by trust here, #12,742 by citations
- Cancer Research — 35 citations into it; #1,714 of 1,780 by trust here, #1,091 by citations
- Oncology — 15 citations into it
Whom Diana Calogrias trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Massagué (in Molecular Biology)
- I. J. Fidler (in Oncology)
Who trusts Diana Calogrias
- H. Horlings (in Molecular Biology)
Papers from Diana Calogrias's perspective
Ordered by how strongly the researchers Diana Calogrias trusts endorse each paper. Same corpus, a different order for every researcher.
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
- Endogenous human microRNAs that suppress breast cancer metastasis (Nature)
- MicroRNA targeting specificity in mammals: determinants beyond seed pairing. (Molecules and Cells)
- Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature)
- MicroRNA signatures in human cancers (Nature Reviews. Cancer)
- Systemic spread is an early step in breast cancer. (Cancer Cell)
- A gene-expression signature as a predictor of survival in breast cancer. (New England Journal of Medicine)
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. (Proceedings of the National Academy of Sciences of the United States of America)
- A microRNA expression signature of human solid tumors defines cancer gene targets (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- A Pleiotropically Acting microRNA, miR-31, Inhibits Breast Cancer Metastasis (2009) — 877 citations
- Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. (2010) — 947 citations